ALB and coronary artery disorder: Recently, several publications confirmed that fibrinogen-to-albumin ratio (FAR), which comprised these two indicators above, was a well-established prognostic factor in esophageal, liver and breast cancers [12–14], and had a closely association with the severity of coronary lesions as well as short-term prognosis in patients with CAD [15–17].